利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

1263 条记录 (耗时 0.026 秒)

    Permeable and semi permeable substrate and substance
    3.
    发明授权
    Permeable and semi permeable substrate and substance 有权

    公开(公告)号：US12058998B1

    公开(公告)日：2024-08-13

    申请号：US17500075

    申请日：2021-10-13

    申请人： Christina Rahm Cook

    发明人： Christina Rahm Cook

    IPC分类号： A23L33/16 ,  A01N25/08 ,  A01N59/00 ,  A01N59/16 ,  A61K33/00 ,  A61K33/38

    CPC分类号： A01N25/08 ,  A01N59/00 ,  A01N59/16 ,  A23L33/16 ,  A61K33/00 ,  A61K33/38 ,  A23V2002/00

    摘要： The present invention provides a permeable and options for semi-permeable inevitable substrate and substance made from minerals, vitamins, and detox formulas and is derived from the manufacturing process of the present invention. In one embodiment, the permeable inevitable substrate and substance may be used in clothing or other articles to be worn, in hospital settings, areas of nuclear waste, areas high in toxins, or areas of high radiation that may enable the radiation, the high energy levels and the toxins to activate the substrates and formulas that have been infused into clothing to self-clean and detox the clothing while it is being worn. In another embodiment, semi-permeable methods may be used by utilizing various forms of silicas and ortho silicates to ensure that positive molecules and ions are able to be diffused, while keeping out negative ions and minerals by diffusion or breaking apart the negative compositions.

    Method for forming a silver-containing nanocomposite pharmaceutical compound
    4.
    发明授权
    Method for forming a silver-containing nanocomposite pharmaceutical compound 有权

    公开(公告)号：US12029758B2

    公开(公告)日：2024-07-09

    申请号：US18295863

    申请日：2023-04-05

    申请人： Imam Abdulrahman Bin Faisal University

    发明人： B. Rabindran Jermy ,  Vijaya Ravinayagam ,  Suriya Rehman

    IPC分类号： A61K33/38 ,  A61K33/243 ,  A61K47/02 ,  A61P31/04

    CPC分类号： A61K33/38 ,  A61K33/243 ,  A61K47/02 ,  A61P31/04

    摘要： A medicinal nanocomposite is provided. The medicinal nanocomposite includes 80 to 99 wt. % carrier particles of a porous silicate material selected from a group including mesoporous silica, silicalite, mesosilicalite, silver-incorporated silicalite, and silver-incorporated mesosilicalite, the carrier particles comprising a pore framework, 0.5 to 10 wt. % silver nanoparticles (Ag NPs) disposed the pore framework, and 0.5 to 10 wt. % of a platinum-containing pharmaceutical compound disposed on at least one surface selected from an interior pore surface of the carrier particles, an exterior surface of the carrier particles, and a surface of the silver nanoparticles. The medicinal nanocomposite releases less than 10 mole % of the platinum-containing pharmaceutical compound after 60 to 84 hours at a pH of 4.5 to 7, based on an initial amount of the platinum-containing pharmaceutical compound present in the medicinal nanocomposite.